Abstract The coronavirus disease‐19 (COVID‐19) pandemic has become a global threat
since its first outbreak at the end of 2019. Several review articles have been published …

Objectives COVID-19 is a transmissible illness triggered by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). Since its onset in late 2019 in Wuhan city of China …

The major challenges encountered by medical researchers in develo** new drugs are
time consumption, increased cost, establishing a safety profile for the drugs, poor solubility …

In December 2019, a new severe acute respiratory syndrome coronavirus (SARS-CoV-2),
causing coronavirus disease 2019 (COVID-19), emerged in Wuhan, China. Despite …

The inhibition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main
protease (Mpro) and papain-like protease (PLpro) prevents viral multiplications; these viral …

COVID-19 has infected millions and significantly affected the global economy and
healthcare systems. Despite continuous lockdowns, symptomatic management with …

Since the beginning of the COVID-19 pandemic, large in silico screening studies and
numerous in vitro studies have assessed the antiviral activity of various drugs on SARS-CoV …

As the world desperately searches for ways to treat the coronavirus disease 2019 (COVID-
19) pandemic, a growing number of people are turning to herbal remedies. The Artemisia …

Abstract Purpose of Review This article provides a review of the recent literature related to
the FDA-approved drugs that had been repurposed as potential drug candidates against …

The current COVID-19 pandemic has elicited extensive repurposing efforts (both small and
large scale) to rapidly identify COVID-19 treatments among approved drugs. Herein, we …